Brief: RA Capital Management, L.P. Reports 9.99% Passive Stake In Urogen Pharma As Of December 19
29/12/2023 22:11
Dec 29 (Reuters) - Urogen Pharma Ltd UR8.F :
* RA CAPITAL MANAGEMENT, L.P. REPORTS 9.99% PASSIVE STAKE IN
UROGEN PHARMA LTD AS OF DECEMBER 19- SEC FILING
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors